サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1540983

免疫血液学市場レポート：製品、技術、用途、エンドユーザー、地域別、2024年～2032年

Immunohematology Market Report by Product, Technology (Biochips, Gel Cards, Microplates, Polymerase Chain Reaction, Erythrocyte-Magnetized Technology, and Others), Application, End-User, and Region 2024-2032

出版日
発行
IMARC
ページ情報
英文 135 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
免疫血液学市場レポート：製品、技術、用途、エンドユーザー、地域別、2024年～2032年
出版日: 2024年08月10日
発行: IMARC
ページ情報: 英文 135 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の免疫血液学市場規模は2023年に19億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに28億米ドルに達し、2024年から2032年の間に4.2%の成長率（CAGR）を示すと予測しています。

免疫血液学は、免疫系に関連する血液や造血組織を研究する医学の一分野です。血液中の抗原の存在と、溶血や赤血球凝集を引き起こす抗体との反応を研究します。さまざまな免疫血液学的検査は、安全な輸血を確保し、望ましくない免疫反応、移植反応、妊娠反応を予防するため、またHIV、肝炎などの血液関連疾患や疾病を診断するために行われます。これらの検査には、マイクロプレート、バイオチップ、ゲルカード、ポリメラーゼ連鎖反応、赤血球磁化技術（EMT）などの技術に基づく試薬、自動・半自動分析装置など、さまざまな化学薬品や装置が利用されます。

世界中で白血病やその他の血液疾患の有病率が増加していることが、市場の成長を促進する主な要因の一つです。さらに、ヘルスケア・インフラの改善や、特に新興諸国における血液バンクや外傷センターの開拓も、市場の成長を後押ししています。血液の採取、処理、検査、保存に関連する活動に対する大衆の意識の高まりは、免疫血液検査装置の需要にさらに好影響を与えています。さらに、革新的な輸血システムや全自動装置の開発など、さまざまな技術の進歩も成長を促す要因となっています。これらの次世代免疫血液検査装置は、診断の有効性を高め、分析時間とヒューマンエラーのリスクを最小限に抑え、患者に緊急支援を提供するのに役立ちます。献血キャンプや啓発プログラムの増加、ヘルスケアインフラの改善など、その他の要因も市場をさらに牽引すると予測されます。

本レポートで扱う主な質問

  • 世界の免疫血液学市場はこれまでどのように推移し、今後どのように推移していくのか？
  • 主要な地域市場は？
  • COVID-19は世界の免疫血液学市場にどのような影響を与えたか？
  • 製品別の市場内訳は？
  • 技術別の市場内訳は？
  • 用途別の市場内訳は？
  • エンドユーザー別の市場内訳は？
  • 業界のバリューチェーンにおける様々な段階とは？
  • 業界の主要な促進要因と課題は何か？
  • 世界の免疫血液学市場の構造と主要プレーヤーは？
  • 業界の競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の免疫血液学市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品別

  • システムの分析
    • 市場動向
    • 市場予測
  • 試薬および消耗品
    • 市場動向
    • 市場予測

第7章 市場内訳：技術別

  • バイオチップ
    • 市場動向
    • 市場予測
  • ジェルカード
    • 市場動向
    • 市場予測
  • マイクロプレート
    • 市場動向
    • 市場予測
  • ポリメラーゼ連鎖反応
    • 市場動向
    • 市場予測
  • 赤血球磁化技術（EMT）
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 市場内訳：用途別

  • 血液関連疾患
    • 市場動向
    • 市場予測
  • HIV
    • 市場動向
    • 市場予測
  • 肝炎
    • 市場動向
    • 市場予測
  • 輸血
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 市場内訳：エンドユーザー別

  • 病院
    • 市場動向
    • 市場予測
  • 血液銀行
    • 市場動向
    • 市場予測
  • 診断検査室
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第10章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abbott
    • Antisel
    • BD（Becton Dickinson and Company）
    • Beckman Coulter Inc.（Danaher Corporation）
    • Bio-Rad Laboratories Inc.
    • F. Hoffmann-La Roche Ltd.
    • Grifols S.A.
    • Merck KGaA
    • MTC Invitro Diagnostics AG
    • Ortho-Clinical Diagnostics Inc（The Carlyle Group）
    • Siemens Healthcare GmbH
    • Thermo Fisher Scientific Inc.
図表

List of Figures

  • Figure 1: Global: Immunohematology Market: Major Drivers and Challenges
  • Figure 2: Global: Immunohematology Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Immunohematology Market: Breakup by Product (in %), 2023
  • Figure 4: Global: Immunohematology Market: Breakup by Technology (in %), 2023
  • Figure 5: Global: Immunohematology Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Immunohematology Market: Breakup by End-User (in %), 2023
  • Figure 7: Global: Immunohematology Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Immunohematology Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 9: Global: Immunohematology (Analyzing Systems) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Immunohematology (Analyzing Systems) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Immunohematology (Reagents and Consumables) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Immunohematology (Reagents and Consumables) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Immunohematology (Biochips) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Immunohematology (Biochips) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Immunohematology (Gel Cards) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Immunohematology (Gel Cards) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Immunohematology (Microplates) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Immunohematology (Microplates) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Immunohematology (Polymerase Chain Reaction) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Immunohematology (Polymerase Chain Reaction) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Immunohematology (Erythrocyte-Magnetized Technology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Immunohematology (Erythrocyte-Magnetized Technology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Immunohematology (Other Technologies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Immunohematology (Other Technologies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Immunohematology (Blood-Related Diseases) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Immunohematology (Blood-Related Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Immunohematology (HIV) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Immunohematology (HIV) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Immunohematology (Hepatitis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Immunohematology (Hepatitis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Immunohematology (Blood Transfusion) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Immunohematology (Blood Transfusion) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Immunohematology (Others) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Immunohematology (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Immunohematology (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Immunohematology (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Global: Immunohematology (Blood Banks) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Global: Immunohematology (Blood Banks) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Global: Immunohematology (Diagnostic Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Global: Immunohematology (Diagnostic Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Global: Immunohematology (Other End-Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Global: Immunohematology (Other End-Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: North America: Immunohematology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: North America: Immunohematology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: United States: Immunohematology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: United States: Immunohematology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Canada: Immunohematology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Canada: Immunohematology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Asia Pacific: Immunohematology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Asia Pacific: Immunohematology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: China: Immunohematology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: China: Immunohematology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Japan: Immunohematology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Japan: Immunohematology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: India: Immunohematology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: India: Immunohematology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: South Korea: Immunohematology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: South Korea: Immunohematology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Australia: Immunohematology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Australia: Immunohematology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Indonesia: Immunohematology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Indonesia: Immunohematology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Others: Immunohematology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Others: Immunohematology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Europe: Immunohematology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Europe: Immunohematology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Germany: Immunohematology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Germany: Immunohematology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: France: Immunohematology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: France: Immunohematology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: United Kingdom: Immunohematology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: United Kingdom: Immunohematology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Italy: Immunohematology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Italy: Immunohematology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Spain: Immunohematology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Spain: Immunohematology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Russia: Immunohematology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Russia: Immunohematology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Others: Immunohematology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Others: Immunohematology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Latin America: Immunohematology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: Latin America: Immunohematology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Brazil: Immunohematology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 84: Brazil: Immunohematology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 85: Mexico: Immunohematology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 86: Mexico: Immunohematology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 87: Others: Immunohematology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 88: Others: Immunohematology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 89: Middle East and Africa: Immunohematology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 90: Middle East and Africa: Immunohematology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 91: Global: Immunohematology Industry: SWOT Analysis
  • Figure 92: Global: Immunohematology Industry: Value Chain Analysis
  • Figure 93: Global: Immunohematology Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Immunohematology Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Immunohematology Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Immunohematology Market Forecast: Breakup by Technology (in Million US$), 2024-2032
  • Table 4: Global: Immunohematology Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 5: Global: Immunohematology Market Forecast: Breakup by End-User (in Million US$), 2024-2032
  • Table 6: Global: Immunohematology Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Immunohematology Market: Competitive Structure
  • Table 8: Global: Immunohematology Market: Key Players
目次
Product Code: SR112024A2256

The global immunohematology market size reached US$ 1.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2.8 Billion by 2032, exhibiting a growth rate (CAGR) of 4.2% during 2024-2032.

Immunohematology refers to a branch of medical sciences that studies blood and blood-forming tissues in relation to the immune system. It is used to study the presence of antigens in the blood and their reaction with antibodies that can either cause hemolysis or red blood cell (RBC) agglutination. Various immunohematology tests are conducted to ensure safe blood transfusion and prevent undesired immunity-, transplant-, and pregnancy-related reactions, and to diagnose blood related disorders and diseases such as HIV, Hepatitis, etc. They utilize various chemicals and devices, such as reagents, and automatic and semi-automatic analyzers that are based on the technology of microplates, biochips, gel cards, polymerase chain reaction and erythrocyte-magnetized technology (EMT).

The increasing prevalence of leukemia and other hematological disorders across the globe is one of the key factors driving the growth of the market. Furthermore, improvements in the healthcare infrastructure and the development of blood banks and trauma centers, especially in developing countries, is also providing a boost to the market growth. Increasing awareness among the masses regarding the activities associated with blood collection, processing, testing and storage has further created a positive impact on the demand for immunohematology devices. Additionally, various technological advancements, such as the development of innovative transfusion systems and fully-automated devices, are acting as other growth-inducing factors. These next-generation immunohematology devices aid in enhancing the efficacy of the diagnosis, minimizing analysis time and risk of human error, and providing emergency assistance to the patients. Other factors, including an increasing number of blood donation camps and awareness programs, along with improvements in the healthcare infrastructure, are projected to drive the market further.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global immunohematology market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, technology, application and end-user.

Breakup by Product:

Analyzing Systems

Reagents and Consumables

Breakup by Technology:

Biochips

Gel Cards

Microplates

Polymerase Chain Reaction

Erythrocyte-Magnetized Technology (EMT)

Others

Breakup by Application:

Blood-Related Diseases

HIV

Hepatitis

Blood Transfusion

Others

Breakup by End-User:

Hospitals

Blood Banks

Diagnostic Laboratories

Others

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Abbott, Antisel, BD (Becton Dickinson and Company), Beckman Coulter Inc. (Danaher Corporation), Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Grifols S.A., Merck KGaA, MTC Invitro Diagnostics AG, Ortho-Clinical Diagnostics Inc (The Carlyle Group), Siemens Healthcare GmbH, Thermo Fisher Scientific Inc., etc.

Key Questions Answered in This Report:

  • How has the global immunohematology market performed so far and how will it perform in the coming years?
  • What are the key regional markets?
  • What has been the impact of COVID-19 on the global immunohematology market?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end-user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global immunohematology market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Immunohematology Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Analyzing Systems
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Reagents and Consumables
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Biochips
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Gel Cards
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Microplates
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Polymerase Chain Reaction
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Erythrocyte-Magnetized Technology (EMT)
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Blood-Related Diseases
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 HIV
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Hepatitis
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Blood Transfusion
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by End-User

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Blood Banks
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Diagnostic Laboratories
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Antisel
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 BD (Becton Dickinson and Company)
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Beckman Coulter Inc. (Danaher Corporation)
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 SWOT Analysis
    • 14.3.5 Bio-Rad Laboratories Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 F. Hoffmann-La Roche Ltd.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 SWOT Analysis
    • 14.3.7 Grifols S.A.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Merck KGaA
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 MTC Invitro Diagnostics AG
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
    • 14.3.10 Ortho-Clinical Diagnostics Inc (The Carlyle Group)
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 SWOT Analysis
    • 14.3.11 Siemens Healthcare GmbH
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Thermo Fisher Scientific Inc.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis